INTERNATIONAL PATENT: SMITH, JILL FILES APPLICATION FOR "THERAPY WITH LOW DOSE NALTREXONE TO IMPROVE EFFICACY OF BIOLOGIC AND IMMUNE MODULATORTHERAPEUTIC AGENTS"

GENEVA, Sept. 17 -- SMITH, Jill (129 North 30th StCamp Hill, Pennsylvania 17011) filed a patent application (PCT/US2025/018186) for "THERAPY WITH LOW DOSE NALTREXONE TO IMPROVE EFFICACY OF BIOLOGIC AND IMMUNE MODULATORTHERAPEUTIC AGENTS" on Mar 03, 2025. With publication no. WO/2025/188650, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SMITH, Jill (129 North 30th StCamp Hill, Pennsylvania 17011)

Abstract: The use of low dose naltrexone as an adjuvant therapy to the use of biologic and/or immune modulator therapies is...